Molecular 'clock' could predict risk for developing breast cancer

May 14, 2008

A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman's risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.

In a study published in today's issue of Cancer Epidemiology Biomarkers & Prevention, scientists from UT Southwestern show that the chemical process, called methylation, is strongly correlated with breast-cancer risk and with precancerous changes in the breast cells.

The researchers determined that methylation acts as a type of biological clock, indicating how many times a cell has divided. This information could aid researchers in determining an individual's cancer risk.

"The more a cell has divided, the greater the risk for cancer," said Dr. David Euhus, professor of surgical oncology. "Monitoring methylation levels could give researchers a way of seeing how often cells have divided and where a woman stands on that clock. Once the clock reaches a certain hour, breast cancer is more likely to ensue."

During methylation, small molecules called methyl groups attach themselves to a gene and turn off, or "silence," the gene.

Previous studies by Dr. Euhus have shown that apparently normal breast cells from women with breast cancer had increased methylation of a tumor-suppressor gene called RASSF1A.

In the current study, Dr. Euhus wanted to see if methylation of RASSF1A and other genes increased over time during the years when the ovaries are actively secreting estrogen and progesterone each month.

Dr. Euhus and his team sampled cells from 164 women - women with breast cancer, women at high risk of developing breast cancer, and women with a low risk for the disease. The researchers examined methylation levels of five tumor-suppressor genes whose job is to stop tumors from developing in the breast.

A computer program developed by Dr. Euhus was used to determine the breast-cancer risk for patients in the study. Dr. Euhus has written several interactive software tools for risk measurement, which are used by major cancer centers worldwide.

His findings indicate that methylation of RASSF1A and other genes increases steadily during the years of ovarian cycling - up to about age 55 - suggesting that methylation is, indeed, a molecular clock recording the history of cell divisions.

"Interestingly, having children, which is known to reduce breast-cancer risk if it occurs early in life, was associated with a reduction in methylation for some genes," Dr. Euhus said.

Dr. Euhus says the clock is not always marching forward, and there are ways to turn it back.

"Methylation can be stopped or slowed down," said Dr. Euhus, who also directs the Mary L. Brown Breast Cancer Genetics and Risk Assessment Program at the Harold C. Simmons Comprehensive Cancer Center. "We found that having a baby set the clock backward and so did getting close to menopause. Things that are known to reduce breast-cancer risk may also turn the clock backward."

A test for methylation of tumor-suppressor genes is not commercially available and Dr. Euhus says additional research is necessary to fully understand the mechanism. For example, it is not clear whether tumor-suppressor gene methylation is simply a marker of prior cell divisions, or whether it can cause increased cell division, hastening the development of breast cancer.

Dr. Euhus said medications that interfere with methylation might provide a new approach for reducing breast-cancer risk.

"Even if there's a lot of methylation, I can't tell for sure if a woman is going to develop breast cancer," Dr. Euhus said. "However, if I took two women from our study and one had more methylation than the other, the one with more methylation was more likely to have already had breast biopsies for benign disease, or had already been diagnosed with breast cancer."

Measuring tumor-suppressor gene methylation might not work well to predict breast-cancer risk in all women. For women with a strong family history of breast cancer, the concept won't work because those breast cancers are associated with DNA repair issues and not methylation, Dr. Euhus said.

UT Southwestern Medical Center

---

---

	Methyl Magic: Maximum Health Through Methylation by Bill Lawren (Author), Kilmer S. McCully (Author), Craig Cooney (Foreword) Text, for consumers, describing strategies based on the body's simplest chemical grouping: the methyl group. Details supplements, diet, and exercise strategies for boosting a person's methyl power for increased energy, a trimmer shape, and a healthy mental attitude.
	The Methylation Miracle: Unleashing Your Body's Natural Source of SAM-e by Paul Frankel (Author) Suddenly everyone is buzzing about SAMe, an extraordinary natural chemical we all manufacture. When SAMe levels are increased, some amazing things start happening--many people have found relief from such debilitating illnesses as depression and liver disease. Now, based on his own revolutionary findings, Dr. Paul Frankel explains a safe, natural, groundbreaking program of supplements, diet changes, and lifestyle modification that will enhance your body's natural methylation process--the one that creates SAMe. This biochemical reaction also reduces the risk of cancer, premature aging, and heart disease, as well as protecting our bodies from harmful toxins, promoting optimum health and well-being. Discover The Methylation Miracle today and find out how this extraordinary program can...
	The H-Factor Solution by ReadHowYouWant THE H-FACTOR SOLUTION: Homocysteine is the Best Single Indicator of Whether You Are Likely to Live Long or Die Young. Staying healthy, happy, clearheaded, and full of energy into old age - this is what we all want. But insuring that we do depends on how well we can ''read'' the state of our health. What if there was a single test that could do that, as well as point the way to a superhealthy future? Fortunately, there is. This test measures your level of homocysteine, an amino acid that is found naturally in the blood. High levels of homocysteine, or a high ''H score,'' predicts your risk of more than 100 diseases and medical conditions, including Alzheimer's disease, cardiovascular disease, cancer, and depression. In fact, it is even more accurate than a cholesterol reading for...
	DNA Methylation: Methods and Protocols (Methods in Molecular Biology) by Jörg Tost (Editor) Over the past few years, DNA methylation technologies and our knowledge of DNA methylation patterns have been advancing at a breathtaking pace. Due to this fact, DNA Methylation: Methods and Protocols, Second Edition completely revises, updates, and expands upon the popular first edition with the most current novel techniques, easier to use and more refined by the tested experience of leading experts. This revision reflects contemporary study of the subject: the analysis of gene-specific DNA methylation patterns has been complemented by genome-wide approaches, and epigenomics takes a central place. Written in the highly successful Methods in Molecular Biology™ series format, the chapters in this volume present brief introductions to the topics, lists of the necessary materials and...
	DNA Methylation, Epigenetics and Metastasis (Cancer Metastasis - Biology and Treatment) by Manel Esteller (Editor) This book provides a broad and rich outline of the epigenetic mechanisms involved in cancer progression and the generation of metastasis. It describes the tumor suppressor genes undergoing transcriptional silencing by CpG island promoter hypermethylation in the different tumor types of the human anatomy and their association with tumoral behaviour. It also provides a comprehensive insightful look at the molecular players involved in DNA methylation, histone modification and chromatin remodelling complexes causing epigenetic lesions linked to the metastasic phenotypes. Finally, it explains how epigenetic lesions associated with cancer spreading can be targeted using new and potent chemotherapy drugs. The book is a state-of-the-art reference to all scientific researchers and clinicians...
	DNA Methylation Microarrays: Experimental Design and Statistical Analysis (Chapman & Hall/CRC Biostatistics Series) by Sun-Chong Wang (Author), Art Petronis (Author) Providing an interface between dry-bench bioinformaticians and wet-lab biologists, DNA Methylation Microarrays: Experimental Design and Statistical Analysis presents the statistical methods and tools to analyze high-throughput epigenomic data, in particular, DNA methylation microarray data. Since these microarrays share the same underlying principles as gene expression microarrays, many of the analyses in the text also apply to microarray-based gene expression and histone modification (ChIP-on-chip) studies. After introducing basic statistics, the book describes wet-bench technologies that produce the data for analysis and explains how to preprocess the data to remove systematic artifacts resulting from measurement imperfections. It then explores differential methylation and genomic...
	DNA Methylation: Basic Mechanisms (Current Topics in Microbiology and Immunology) by Walter Doerfler (Editor), Petra Böhm (Editor) The structural and functional importance of the correct patterns of DNA methylation in all parts of a mammalian genome is, unfortunately, not well understood. The stability, inheritability, and developmental flexibility of these patterns all point to a major role that these patterns appear to play in determining structure and function of the genome. Up to the present time, studies on the repetitive sequences, which comprise more than 90 per cent of the DNA sequences in the human or other genomes, have been neglected.
	DNA Methylation and Cancer Therapy (Medical Intelligence Unit) by Moshe Szyf (Author) This book provides a comprehensive analysis of implications of DNA methylation on cancer diagnosis and cancer therapy. This unique volume focuses on cancer therapy by thoroughly dissecting the basic principles of DNA methylation in cancer from molecular mechanisms to clinical trials. The chapters are written by leading experts in the field and are designed to provide the reader with the necessary background to evaluate critically the potential of DNA methylation in cancer therapy. Key features of this book include discussions of the following topics: The molecular machinery responsible for DNA methylation and their impact on gene expression and tumorigenesis. The emerging relation between DNA methylation and chromatin modifying proteins. How the relationship between DNA methylation and...
	DNA Methylation Protocols (Methods in Molecular Biology) by Ken I. Mills (Editor), Bernie H. Ramsahoye (Editor) DNA Methylation Protocols offer a set of readily reproducible protocols of the analysis of DNA methylation and methylases. These powerful methods provide the tools necessary for studying methylation at both the global level and the level of sequence, and include many techniques for identifying genes that might be aberrantly methylated in cancer and aging. Additional methods cover genome-wide analysis of abnormal DNA methylation and the isolation and measurement of demethylases and related proteins.
	DNA Methylation: Approaches and Applications by Manel Esteller (Editor) DNA Methylation: Approaches, Methods and Applications describes the relation DNA methylation has to gene silencing in disease, and explores its promising role in treating cancer. Written by leaders in the field, this exceptional compilation of articles outlines the best techniques to use when addressing questions concerning the cytosine methylation status of genomic DNA. It includes concepts, experimental models, and clinical uses of demethylating agents. The book provides a balance between articles clarifying methodological details and more general review chapters that offer broad biological perspectives on DNA methylation. This is an invaluable handbook for researchers and clinicians interested in genetics and molecular biology, particularly epigenetic therapies and gene silencing.